pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol CLASP2   
Synonyms -
Description cytoplasmic linker associated protein 2
Transcript NM_015097   
Expression
Putative miRNA Targets on CLASP2
3'UTR of CLASP2
(miRNA target sites are highlighted)
>CLASP2|NM_015097|3'UTR
   1 TGAAGCTCATCACAGCGAACCAGGTCTCTCAAAAGAAAGGACAGATAGACCACCCTCATCAATGAAAGGAAGTTCTCAAA
  81 CACATCCTTTGGAACTTACTATTGTTTCCCAGTTTTAGTTTTTTGTTTCGTTTCGTTTTGTATTTTCTGTAACAGAGGAC
 161 TATCCTCAGTCTGCATGTAACTTTTATGATAGTTATTCCAAATTCAAGAAGAAGCAGTATTAACATCAATTGATCGACAC
 241 AAAGTAATTTTTAATTTAATTCATCATTTCACATGTTTGTACTTTGTCTTCCCATTAACCTTTGCCAGTGTTATGATTGT
 321 ATAAATTTTTTTAAATGCTGGTTAAACAGGAATGCTTAAAGCTTTAAAAGTTTAACAGTCTAAAACATTTTTGCTTTTAT
 401 TCAACTGCAGAATAATATTTTTATTGCTACTTTGAGTTTTGTTTCGTATCATGTCCTATGCTAGAAATATTTAAATGATG
 481 TGAAACAAAGCAGGACTAATTTGAACTACAGCTGGACTCCGTTTGTGTGATGGTGATACATGTCATTAGTTGCAACTTCT
 561 TTGGGGTGATCTATAGTTTGAAAACTAAAACCTCAAAGACAGATGTTACAGAATCAGCCAGTTCTGTAAAACTGATATTG
 641 TCTATTGGTTATTGATCTTGCCATCTTTATTTAAAACCATGTCCCTTCTATGATCCCTTAAGAAAGCTGCACCAAATCAT
 721 CTGCCTGTTTTTTCTTGATACTTACTGAAATAGAAGGTTTTATTGCAGGGTTTATTTTGGTTTGTTTATATCTTTGTTGT
 801 GAATGATGCTTTTTTGTATTTATTAATATCAAATTCACTTATGAATAAACTTGATAATGGAAACGGACAAAAAAAATCAA
 881 GTGCGTGTGTGTCCTTGACCGTCTTCTGTTTCTCACGTAATAAACAAATTATCGAGACATGGGAGTGACCAGCACCTTTT
 961 CTTTAAATGGTGGAACCTGGTTTCCTTTTACCATGAAATTGTCTTACTTGAAAATATTGATCCTGATGAGAGAGAAGATG
1041 GTGCCAAGGCTGTCTTTGTATAATGGGCTCAAATTCTCTACCTCTTCAGGGCTAATACTTTTAACTGAGCTGCTGCCTAT
1121 AGTGTCTTTTGGAAAACTACTTAAAGGGTGATTTTCTGTTACTTTTTAGCAAATTTTTTTAATCACCTCTTGCTACACCC
1201 ATTCTTTTCATGTGCAGCCGACTCAAAAATTACCAGTTTTGGTGAAAGGCTAAATTAGATAATTTGGAACCAGGATACTA
1281 ATGATTTCTCATCTTTACTTTTTTTTAATCCTAATATAAAGTGAATTTGATTGAAAAGGCAAATAGCTATTAGGGAAGCA
1361 GTTTGCCATTGTTGCAGAGTTATCTGTACTTTGTTTAACTGAAAAAAATGTAGAAATATATGTAAAGAATTTAAGACAAG
1441 AGTACTGAATGGATGATTTGTCATAGGCTTTCCCCTTTCTTTCTGTTCTAGCAGCAGGAAAAGTTTCTCTATATCCTCTC
1521 CCTCTACCTGTAACAATTTTGTTTTCTACTGTTAATTACATTGTGTATTTATAGTTCTATGCTTACTGTTGTGCATATAC
1601 TGGCAATAAAACTGTACATAACATTACTTGAAAAAGTTAATAATGTATATCAGTTTTTCTGTCTCACTGTGTAACAAGTC
1681 ACTCAGTTTTATTTTAACTTTAGACGGTCTTGTATCAGTGGTGGTCTCTTGAATTTTGTAAGTTCATCTGAGGAGAAAAG
1761 ATTTTTCAGGTGTAGCTACCACAATCAAAGGTATATAGCTACATACGCATGTATATATTACAGCTTATCTGTAAGAAGAA
1841 AATGCATTTTAAACACAACTCTTCTCAGTAGCATTTTATGACCTTTGGATATGTTTGTAATCATTTCGAATCAAAATATT
1921 GATTTAATTTTGACCTCTGGTTTAAGATACTGCTTTAACTACTGTTGACAACCAAGTAGAGTGACTTAAGCTGAACAGTA
2001 ACTAACTGGAAAATTAGATAAGCACCTGGCATCTAATGGCAGGCAGGCACTCAAGAAATGAATTAACTACATAATGGAAA
2081 AGTATGGTTTAATGTGTCCAAATGAAAGCTAGTAGATGTAAACATGGAAAAATTGTGTTTACAATTTTATAATCTCAGTT
2161 GATAAGACTATAAGAAAGCTGATTATTTAAATCACTATATACAATACACCCTTAATTTGTTCATTCCAGAAACATACTGA
2241 GATGTCAGCTACTTAAAAATGGTCACAAAAAGCTACTGTTTATATTTTTCCTCCTGCTATTCTCTCCCAAATTAATTATT
2321 AATAAGTGTTGTTCATTTACTGCACTGCTGAGAACTAATTAAAATTATATATTCCAGATTGTAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucggCGACAGUGUGCGUGUc 5'
                |||  ||:|||||:: 
Target 5' tatataGCT-ACATACGCATGt 3'
1792 - 1812 123.00 -13.40
2
miRNA  3' agucggcgacagUGUGCGUGUc 5'
                      | ||| ||| 
Target 5' acttgataatggAAACGGACAa 3'
849 - 870 110.00 -6.70
3
miRNA  3' agucGGCGACAGUGUGCGUguc 5'
              |:|:| || ||||:|   
Target 5' tcttCTGTT-TCTCACGTAata 3'
902 - 922 105.00 -12.82
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31479678 2 COSMIC
COSN30580930 16 COSMIC
COSN31491432 18 COSMIC
COSN31494952 23 COSMIC
COSN26574728 26 COSMIC
COSN30102624 26 COSMIC
COSN28575702 60 COSMIC
COSN20074754 87 COSMIC
COSN30111937 129 COSMIC
COSN31575459 129 COSMIC
COSN31608091 134 COSMIC
COSN24407477 135 COSMIC
COSN30122526 142 COSMIC
COSN30162795 155 COSMIC
COSN30623650 169 COSMIC
COSN31492060 200 COSMIC
COSN28671261 230 COSMIC
COSN31528646 265 COSMIC
COSN31607363 327 COSMIC
COSN31551916 333 COSMIC
COSN31556443 364 COSMIC
COSN31520770 445 COSMIC
COSN31530304 624 COSMIC
COSN30172448 737 COSMIC
COSN25039437 866 COSMIC
COSN7606356 933 COSMIC
COSN26641306 969 COSMIC
COSN26643633 992 COSMIC
COSN31517303 1126 COSMIC
COSN30539719 1143 COSMIC
COSN30161112 1224 COSMIC
COSN20090780 1263 COSMIC
COSN1946872 1316 COSMIC
COSN31487974 1413 COSMIC
COSN7606355 1447 COSMIC
COSN16644422 1508 COSMIC
COSN24985957 1529 COSMIC
COSN31487876 1571 COSMIC
COSN31522360 1578 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1326662156 1 dbSNP
rs934218178 2 dbSNP
rs752755158 4 dbSNP
rs1233683123 5 dbSNP
rs893895057 6 dbSNP
rs759726729 8 dbSNP
rs774602926 9 dbSNP
rs368353422 13 dbSNP
rs1327070212 14 dbSNP
rs1317785597 15 dbSNP
rs374145233 17 dbSNP
rs1396965611 19 dbSNP
rs1166030624 23 dbSNP
rs534579392 26 dbSNP
rs1412160752 30 dbSNP
rs371081888 31 dbSNP
rs770289937 36 dbSNP
rs1363043899 40 dbSNP
rs748648284 43 dbSNP
rs776026723 44 dbSNP
rs768189073 45 dbSNP
rs746678976 47 dbSNP
rs1309121641 51 dbSNP
rs756381198 51 dbSNP
rs1366633747 52 dbSNP
rs567456249 58 dbSNP
rs149984919 60 dbSNP
rs753024688 67 dbSNP
rs1238589523 74 dbSNP
rs1434819548 78 dbSNP
rs1441276279 79 dbSNP
rs534510361 81 dbSNP
rs982037392 85 dbSNP
rs915670359 95 dbSNP
rs1174388908 99 dbSNP
rs991171757 101 dbSNP
rs970610049 106 dbSNP
rs1332239125 108 dbSNP
rs938547974 115 dbSNP
rs1324396673 116 dbSNP
rs569871509 117 dbSNP
rs977273405 123 dbSNP
rs1332161992 129 dbSNP
rs1233421706 130 dbSNP
rs967738302 134 dbSNP
rs893586826 135 dbSNP
rs551078785 162 dbSNP
rs777015567 164 dbSNP
rs1458966796 167 dbSNP
rs1021512637 172 dbSNP
rs1449987790 186 dbSNP
rs1392019952 187 dbSNP
rs548635916 190 dbSNP
rs1477601867 191 dbSNP
rs187282824 200 dbSNP
rs112093650 205 dbSNP
rs1171702516 210 dbSNP
rs1426023514 212 dbSNP
rs1464444712 215 dbSNP
rs758061638 215 dbSNP
rs1391819684 217 dbSNP
rs934270386 219 dbSNP
rs901422900 229 dbSNP
rs13954 230 dbSNP
rs1278513335 235 dbSNP
rs1205334883 236 dbSNP
rs528755404 240 dbSNP
rs1319555473 241 dbSNP
rs942878591 244 dbSNP
rs1250564973 246 dbSNP
rs1356724842 253 dbSNP
rs1343465354 256 dbSNP
rs1298444133 257 dbSNP
rs910000360 259 dbSNP
rs984228619 261 dbSNP
rs1028427738 266 dbSNP
rs1476965931 268 dbSNP
rs1169952904 275 dbSNP
rs1369442185 291 dbSNP
rs1275813027 294 dbSNP
rs1406930834 299 dbSNP
rs930021771 314 dbSNP
rs1423529008 318 dbSNP
rs1369006974 325 dbSNP
rs1307491681 332 dbSNP
rs1397773683 335 dbSNP
rs918608410 338 dbSNP
rs1340883730 352 dbSNP
rs982089727 354 dbSNP
rs1263673077 360 dbSNP
rs1358637617 369 dbSNP
rs996955732 376 dbSNP
rs1288265788 386 dbSNP
rs1487327571 386 dbSNP
rs1257099625 402 dbSNP
rs1173805377 406 dbSNP
rs1413870560 410 dbSNP
rs1384932625 418 dbSNP
rs1420856690 419 dbSNP
rs561426194 430 dbSNP
rs1425537569 433 dbSNP
rs1192765137 437 dbSNP
rs1450952482 440 dbSNP
rs901246930 446 dbSNP
rs1397633669 450 dbSNP
rs1312650882 451 dbSNP
rs1020238282 452 dbSNP
rs543352920 456 dbSNP
rs767964986 458 dbSNP
rs1351664531 460 dbSNP
rs1215141589 463 dbSNP
rs1256883094 473 dbSNP
rs1004384825 482 dbSNP
rs887363046 491 dbSNP
rs1048593876 496 dbSNP
rs575741805 508 dbSNP
rs1023555106 515 dbSNP
rs930994076 520 dbSNP
rs183359869 521 dbSNP
rs544684003 528 dbSNP
rs957905473 530 dbSNP
rs1416846799 532 dbSNP
rs894122402 533 dbSNP
rs1157727586 541 dbSNP
rs1377630004 552 dbSNP
rs552727986 555 dbSNP
rs1334229678 560 dbSNP
rs1312133693 570 dbSNP
rs773405822 573 dbSNP
rs772326127 581 dbSNP
rs928400382 586 dbSNP
rs902243976 601 dbSNP
rs977660604 602 dbSNP
rs1371088540 607 dbSNP
rs1223082053 609 dbSNP
rs1313979119 620 dbSNP
rs1231380984 623 dbSNP
rs151330210 627 dbSNP
rs1458528942 632 dbSNP
rs997128512 638 dbSNP
rs1236949354 641 dbSNP
rs533562026 676 dbSNP
rs901470421 681 dbSNP
rs1039933957 686 dbSNP
rs1434355494 693 dbSNP
rs774265010 695 dbSNP
rs1428150969 710 dbSNP
rs878919072 712 dbSNP
rs1053382 713 dbSNP
rs1172565399 718 dbSNP
rs1410688800 724 dbSNP
rs1375572216 726 dbSNP
rs1441422107 737 dbSNP
rs1294003722 739 dbSNP
rs1301183390 740 dbSNP
rs1403155446 745 dbSNP
rs1282943070 747 dbSNP
rs552509402 747 dbSNP
rs114867165 750 dbSNP
rs1178287005 757 dbSNP
rs1455491265 780 dbSNP
rs1410992842 787 dbSNP
rs1159394836 788 dbSNP
rs990041075 789 dbSNP
rs567298650 792 dbSNP
rs1489210016 796 dbSNP
rs1049015572 799 dbSNP
rs1267473489 807 dbSNP
rs776090864 809 dbSNP
rs1180832166 812 dbSNP
rs1477953125 813 dbSNP
rs774150058 816 dbSNP
rs1195339776 822 dbSNP
rs1483204026 825 dbSNP
rs1238594410 826 dbSNP
rs1028358814 832 dbSNP
rs1165453328 863 dbSNP
rs555361912 865 dbSNP
rs3209345 868 dbSNP
rs965887033 872 dbSNP
rs544839034 877 dbSNP
rs1019659082 878 dbSNP
rs1341147514 884 dbSNP
rs1004796267 885 dbSNP
rs563542216 887 dbSNP
rs1319015583 889 dbSNP
rs887248337 891 dbSNP
rs1027213582 893 dbSNP
rs1292728040 897 dbSNP
rs1395565888 900 dbSNP
rs866392408 901 dbSNP
rs190370584 913 dbSNP
rs958173157 915 dbSNP
rs1432856886 916 dbSNP
rs1055425493 917 dbSNP
rs925166168 928 dbSNP
rs978319278 931 dbSNP
rs966469576 932 dbSNP
rs1162798712 936 dbSNP
rs1320990474 938 dbSNP
rs1455007569 939 dbSNP
rs938321248 945 dbSNP
rs906954679 950 dbSNP
rs1344828612 951 dbSNP
rs1366416521 955 dbSNP
rs543876183 969 dbSNP
rs1030032965 976 dbSNP
rs1380980635 977 dbSNP
rs1423936321 978 dbSNP
rs997180935 979 dbSNP
rs945886285 981 dbSNP
rs1353863032 983 dbSNP
rs1206366039 989 dbSNP
rs570964473 991 dbSNP
rs768352840 993 dbSNP
rs1463936954 998 dbSNP
rs1054275349 1001 dbSNP
rs1244770026 1008 dbSNP
rs931921969 1026 dbSNP
rs1017657680 1033 dbSNP
rs1380816111 1038 dbSNP
rs548021377 1046 dbSNP
rs1441697068 1052 dbSNP
rs1156902806 1059 dbSNP
rs569729610 1060 dbSNP
rs1407275334 1062 dbSNP
rs921846181 1066 dbSNP
rs975824201 1073 dbSNP
rs888677277 1077 dbSNP
rs1048584578 1078 dbSNP
rs965376478 1079 dbSNP
rs994735641 1082 dbSNP
rs1379754260 1094 dbSNP
rs551622519 1095 dbSNP
rs749186332 1098 dbSNP
rs1277275674 1101 dbSNP
rs1349272996 1105 dbSNP
rs1046526226 1117 dbSNP
rs780211313 1121 dbSNP
rs755400689 1122 dbSNP
rs1027140365 1136 dbSNP
rs1320971713 1137 dbSNP
rs1383742496 1139 dbSNP
rs539099496 1141 dbSNP
rs995628087 1154 dbSNP
rs1264582031 1158 dbSNP
rs1459850078 1159 dbSNP
rs958948994 1162 dbSNP
rs9311015 1164 dbSNP
rs1238492197 1167 dbSNP
rs1179510186 1169 dbSNP
rs546968920 1171 dbSNP
rs916603605 1172 dbSNP
rs1478381402 1174 dbSNP
rs1178916749 1180 dbSNP
rs143936549 1193 dbSNP
rs1469668275 1198 dbSNP
rs561375397 1199 dbSNP
rs1171833655 1207 dbSNP
rs1402830189 1208 dbSNP
rs1458122249 1210 dbSNP
rs1328723149 1219 dbSNP
rs906842265 1220 dbSNP
rs1041757711 1226 dbSNP
rs1448201624 1233 dbSNP
rs1284867286 1235 dbSNP
rs1010015114 1250 dbSNP
rs892885391 1256 dbSNP
rs977988161 1261 dbSNP
rs966516270 1263 dbSNP
rs1341165128 1267 dbSNP
rs1194047734 1272 dbSNP
rs923072483 1273 dbSNP
rs1430616425 1275 dbSNP
rs1452318930 1289 dbSNP
rs1265749598 1290 dbSNP
rs1201676462 1291 dbSNP
rs1266774412 1294 dbSNP
rs1480239237 1299 dbSNP
rs377189598 1302 dbSNP
rs975816271 1304 dbSNP
rs866186709 1306 dbSNP
rs1054330748 1307 dbSNP
rs931764969 1317 dbSNP
rs1460757733 1330 dbSNP
rs1167896179 1334 dbSNP
rs964404603 1349 dbSNP
rs549398496 1353 dbSNP
rs1006287219 1357 dbSNP
rs1343042338 1358 dbSNP
rs541453579 1359 dbSNP
rs1278406828 1361 dbSNP
rs780962061 1371 dbSNP
rs1203185139 1374 dbSNP
rs921854504 1383 dbSNP
rs1341330503 1384 dbSNP
rs1224954984 1393 dbSNP
rs1269595443 1397 dbSNP
rs756895877 1400 dbSNP
rs897342637 1409 dbSNP
rs994387583 1409 dbSNP
rs1025125711 1418 dbSNP
rs1217670370 1427 dbSNP
rs1264094569 1429 dbSNP
rs1040266018 1439 dbSNP
rs1229548257 1440 dbSNP
rs1369356324 1442 dbSNP
rs944057807 1448 dbSNP
rs1162181660 1453 dbSNP
rs1363214489 1463 dbSNP
rs878934434 1464 dbSNP
rs1423434016 1465 dbSNP
rs983177417 1469 dbSNP
rs951503762 1471 dbSNP
rs919970300 1474 dbSNP
rs1380099545 1479 dbSNP
rs1055167753 1485 dbSNP
rs1340792302 1485 dbSNP
rs763071451 1489 dbSNP
rs368729151 1490 dbSNP
rs1305609657 1491 dbSNP
rs1312790988 1498 dbSNP
rs140118930 1499 dbSNP
rs936667739 1499 dbSNP
rs958833818 1502 dbSNP
rs1035033257 1509 dbSNP
rs1042703340 1511 dbSNP
rs573091608 1511 dbSNP
rs1257342018 1519 dbSNP
rs923124890 1520 dbSNP
rs751192337 1524 dbSNP
rs975869013 1526 dbSNP
rs774807276 1531 dbSNP
rs185908045 1536 dbSNP
rs1159206589 1543 dbSNP
rs1364962190 1547 dbSNP
rs1451200108 1552 dbSNP
rs972042274 1561 dbSNP
rs545215804 1571 dbSNP
rs12489451 1577 dbSNP
rs1009904947 1579 dbSNP
rs892895272 1583 dbSNP
rs1334678296 1586 dbSNP
rs1480881661 1587 dbSNP
rs1271367272 1588 dbSNP
rs1391830615 1591 dbSNP
rs577269120 1593 dbSNP
rs755302005 1601 dbSNP
rs754339145 1603 dbSNP
rs996023177 1614 dbSNP
rs1326173626 1615 dbSNP
rs776586824 1616 dbSNP
rs1242850154 1621 dbSNP
rs972998192 1637 dbSNP
rs1179407957 1640 dbSNP
rs961601884 1645 dbSNP
rs771308743 1647 dbSNP
rs766925979 1648 dbSNP
rs1025174897 1651 dbSNP
rs1470872015 1657 dbSNP
rs1040594616 1663 dbSNP
rs1013752198 1666 dbSNP
rs760718228 1669 dbSNP
rs886348620 1671 dbSNP
rs1255181345 1690 dbSNP
rs1299785038 1691 dbSNP
rs879011907 1698 dbSNP
rs1371344078 1703 dbSNP
rs1390881327 1705 dbSNP
rs1047058932 1706 dbSNP
rs895269460 1712 dbSNP
rs559016832 1714 dbSNP
rs1034184872 1720 dbSNP
rs929942952 1724 dbSNP
rs903867230 1726 dbSNP
rs1042348271 1730 dbSNP
rs1207288455 1738 dbSNP
rs1286021061 1740 dbSNP
rs540766477 1742 dbSNP
rs1479404214 1746 dbSNP
rs146137590 1776 dbSNP
rs1408875100 1778 dbSNP
rs920021139 1787 dbSNP
rs1176118204 1793 dbSNP
rs142445044 1798 dbSNP
rs901755254 1799 dbSNP
rs1196788256 1800 dbSNP
rs1330326563 1801 dbSNP
rs1428387585 1806 dbSNP
rs1040218519 1808 dbSNP
rs1172518722 1809 dbSNP
rs974102317 1815 dbSNP
rs1352687049 1820 dbSNP
rs1461364338 1821 dbSNP
rs943203942 1822 dbSNP
rs937408650 1826 dbSNP
rs1400784719 1827 dbSNP
rs927512895 1831 dbSNP
rs1403366848 1841 dbSNP
rs910352140 1842 dbSNP
rs1363149330 1843 dbSNP
rs1216675423 1847 dbSNP
rs1294142073 1860 dbSNP
rs553034041 1862 dbSNP
rs773317657 1878 dbSNP
rs982008593 1880 dbSNP
rs971714312 1882 dbSNP
rs1020917164 1888 dbSNP
rs771556510 1891 dbSNP
rs918940125 1891 dbSNP
rs1219861410 1900 dbSNP
rs1267718408 1905 dbSNP
rs68185169 1907 dbSNP
rs770064875 1908 dbSNP
rs1157163590 1911 dbSNP
rs762039919 1919 dbSNP
rs1367567589 1930 dbSNP
rs1025227068 1932 dbSNP
rs956998596 1935 dbSNP
rs1346004274 1936 dbSNP
rs1032783084 1948 dbSNP
rs995952594 1954 dbSNP
rs1440598333 1955 dbSNP
rs879084192 1965 dbSNP
rs1033826039 1966 dbSNP
rs1204250859 1970 dbSNP
rs1001378035 1981 dbSNP
rs1317753600 1982 dbSNP
rs1243135980 1983 dbSNP
rs968142810 1983 dbSNP
rs900238513 1989 dbSNP
rs1447236917 2004 dbSNP
rs866528427 2005 dbSNP
rs1240178683 2006 dbSNP
rs1009106418 2014 dbSNP
rs1009516377 2016 dbSNP
rs901807464 2023 dbSNP
rs886364072 2024 dbSNP
rs1163011986 2026 dbSNP
rs181036567 2032 dbSNP
rs1047606882 2034 dbSNP
rs929995194 2035 dbSNP
rs148431469 2038 dbSNP
rs1351022915 2039 dbSNP
rs1345021755 2043 dbSNP
rs1040270392 2049 dbSNP
rs898525615 2064 dbSNP
rs1280785062 2069 dbSNP
rs557944978 2076 dbSNP
rs1381234361 2081 dbSNP
rs1052812 2082 dbSNP
rs10764 2093 dbSNP
rs1350719988 2094 dbSNP
rs1225152942 2095 dbSNP
rs547107701 2100 dbSNP
rs1336589469 2112 dbSNP
rs1048867446 2114 dbSNP
rs1328286562 2115 dbSNP
rs189825663 2124 dbSNP
rs1244672394 2135 dbSNP
rs144417703 2140 dbSNP
rs981636983 2142 dbSNP
rs930416188 2143 dbSNP
rs950229536 2144 dbSNP
rs1471187602 2152 dbSNP
rs778501352 2156 dbSNP
rs1407526366 2157 dbSNP
rs1470388576 2161 dbSNP
rs755251872 2164 dbSNP
rs1409072321 2166 dbSNP
rs1179053102 2167 dbSNP
rs913498291 2170 dbSNP
rs949700572 2175 dbSNP
rs1160350628 2177 dbSNP
rs1335879879 2179 dbSNP
rs56906831 2182 dbSNP
rs537523984 2187 dbSNP
rs1349498179 2193 dbSNP
rs568594459 2197 dbSNP
rs974400043 2199 dbSNP
rs1264793222 2203 dbSNP
rs1462611106 2207 dbSNP
rs1245954024 2210 dbSNP
rs1321099859 2217 dbSNP
rs1199850064 2218 dbSNP
rs926808872 2219 dbSNP
rs1439701259 2220 dbSNP
rs80104935 2222 dbSNP
rs968572260 2230 dbSNP
rs1020993209 2232 dbSNP
rs778810985 2236 dbSNP
rs1427694387 2242 dbSNP
rs1009568575 2243 dbSNP
rs1285967024 2259 dbSNP
rs1399257586 2261 dbSNP
rs1408649033 2262 dbSNP
rs11717495 2263 dbSNP
rs1326298311 2264 dbSNP
rs1207721277 2275 dbSNP
rs1019075298 2282 dbSNP
rs1008742643 2290 dbSNP
rs1405213856 2291 dbSNP
rs1284770870 2296 dbSNP
rs950580926 2298 dbSNP
rs966030319 2299 dbSNP
rs531079741 2305 dbSNP
rs563640531 2322 dbSNP
rs1341401657 2329 dbSNP
rs1193951208 2331 dbSNP
rs1247274916 2334 dbSNP
rs1490524221 2338 dbSNP
rs369346163 2345 dbSNP
rs1026083364 2347 dbSNP
rs994740882 2350 dbSNP
rs889023836 2351 dbSNP
rs899078767 2352 dbSNP
rs1375084652 2359 dbSNP
rs1474727045 2371 dbSNP
rs1295851913 2375 dbSNP
rs1038372474 2381 dbSNP
rs1168465815 2384 dbSNP
rs1235914283 2386 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293 , HUVEC , MCF7
Location of target site CDS, 3'UTR
Tools used in this research DIANA-microT , EIMMO , miRanda , miRBase Target Database , PicTar , TargetScan
Article - Fasanaro P; Greco S; Lorenzi M; Pescatori et al.
- The Journal of biological chemistry, 2009
miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.
LinkOut: [PMID: 19826008]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
ESCA -0.624 0.02 -0.682 0.01 11 Click to see details
THCA 0.258 0.02 0.216 0.05 59 Click to see details
KIRC -0.206 0.05 -0.231 0.03 68 Click to see details
KIRP -0.302 0.05 -0.431 0.01 32 Click to see details
STAD -0.284 0.06 -0.284 0.06 32 Click to see details
COAD -0.57 0.07 -0.690 0.03 8 Click to see details
HNSC -0.201 0.1 -0.157 0.16 42 Click to see details
LUSC -0.174 0.15 -0.131 0.22 38 Click to see details
PAAD -0.668 0.17 -0.800 0.1 4 Click to see details
PCPG 0.865 0.17 1.000 0.5 3 Click to see details
LIHC 0.134 0.18 0.122 0.2 49 Click to see details
BRCA -0.096 0.19 -0.142 0.1 84 Click to see details
BLCA -0.214 0.2 -0.176 0.24 18 Click to see details
UCEC -0.172 0.24 -0.116 0.32 19 Click to see details
CHOL 0.265 0.25 0.217 0.29 9 Click to see details
KICH 0.085 0.34 0.083 0.35 25 Click to see details
LUAD 0.075 0.41 0.224 0.24 12 Click to see details
PRAD 0.028 0.42 -0.156 0.14 50 Click to see details
CESC 0.226 0.43 -0.500 0.33 3 Click to see details
CESC 0.226 0.43 -0.500 0.33 3 Click to see details
CESC 0.226 0.43 -0.500 0.33 3 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission